Searched for
LUPIN GENERIC DRUG
Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...
- Lupin launches generic anti-diabetic tablets in USPharma major Lupin has launched its generic anti-diabetic medicine in the United States. The medicine is dapagliflozin and metformin hydroc...
- Lupin launches generic drug to treat depression in USLupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded and generic formulations,...
- Several Indian companies get FDA nod for anti-depressant drugThe US Food and Drug Administration has approved the first generic versions of Cymbalta, a prescription medicine used in treatment of depre...
- Lupin to file new drug application for GSK’s $8 bn blockbuster inhaler AdvairMumbai-based drug maker Lupin Pharma will file an Abbreviated New Drug Application for GSK’s $8-billion dry powder inhaler Advair, said Vin...
- Lupin to challenge Pregabalin ruling by US courtLupin Limited says it will challenge a US court order that prevents it from selling a low-cost generic version of Pfizer's nerve pain drug ...
- Lupin settles patent dispute with US firms over diabetes drugLupin today said it has reached a patent litigation settlement agreement with US-based firms Santarus Inc and Depomed Inc involving diabete...
- Lupin gets USFDA nod for generic cholesterol drugThe US health regulator has granted approval to Lupin to market generic Fenofibrate Tablets, a cholesterol lowering drug, in the American m...
- Lupin launches Generic Diabetes drugIndian pharmaceutical major Lupin launched the generic version of Watson’s Fortamet despite an impeding patent suit against Lupin in the US.
- Lupin gets final US FDA nod for generic anti-epileptic drugLupin is the 5th largest generics player in the US (by prescriptions), the only Asian company to achieve that distinction.
- Novo sues Lupin to block generic in USDanish company Novo Nordisk has sued Mumbai-based drugmaker Lupin to prevent it from launching the low priced version of its patented diabe...
- Lupin buys US rights of anti-cholesterol drug Antara for $39 mnLupin has bought the US marketing rights and inventory for cholesterol-lowering drug Antara from the bankrupt Oscient Pharma for $39 millio...
- Lupin, Novartis end patent row for LotrelLupin has reached an out-ofcourt settlement with Swiss pharma major Novartis for the latter’s hypertension drug sold under the brand name L...
- Lupin to launch more branded generics in USLupin Pharma will launch a new branded generic drug in the US every year for specialised therapeutic areas.
- Lupin close to speciality pharma buy in AmericaDrug maker Lupin plans to acquire a speciality pharmaceutical company in the United States to expand its portfolio of brands in the paediat...
Load More
